Stacy L. Taylor - Jun 17, 2021 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Role
SVP and General Counsel
Signature
/s/ Stacy L. Taylor by Eric Billings as attorney-in-fact
Stock symbol
ADPT
Transactions as of
Jun 17, 2021
Transactions value $
-$103,985
Form type
4
Date filed
6/21/2021, 08:00 PM
Next filing
Jul 1, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADPT Common Stock Options Exercise $8.12K +1.04K +6.92% $7.80 16.1K Jun 17, 2021 Direct F1
transaction ADPT Common Stock Options Exercise $11.6K +1.77K +11.02% $6.55 17.8K Jun 17, 2021 Direct F1
transaction ADPT Common Stock Options Exercise $42.9K +1.35K +7.59% $31.71* 19.2K Jun 17, 2021 Direct F1
transaction ADPT Common Stock Sale -$167K -4.17K -21.7% $40.00* 15K Jun 17, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADPT Stock Option (Right to Buy) Options Exercise $0 -1.04K -4.16% $0.00 24K Jun 17, 2021 Common Stock 1.04K $7.80 Direct F1, F2
transaction ADPT Stock Option (Right to Buy) Options Exercise $0 -1.77K -9.09% $0.00 17.7K Jun 17, 2021 Common Stock 1.77K $6.55 Direct F1, F3
transaction ADPT Stock Option (Right to Buy) Options Exercise $0 -1.35K -2.94% $0.00 44.7K Jun 17, 2021 Common Stock 1.35K $31.71 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020.
F2 The options vested with respect to 1/4 of such shares on April 23, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F3 The options vested with respect to 1/4 of such shares on March 12, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F4 The options vested with respect to 1/4 of such shares on February 13, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.